Source - LSE Regulatory
RNS Number : 5756E
Deltex Medical Group PLC
12 February 2018
 

12 February 2018

 

 

Deltex Medical Group plc

("Deltex Medical", "Deltex" or "the Company")

 

 

Director dealing and issue of equity

 

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM") announces that it has issued 800,000 new Ordinary Shares of 1 pence each in the capital of the Company ("Ordinary Shares") in connection with the exercise of options by Ewan Phillips, Chief Executive Officer, granted under the Company's Enterprise Management Incentive Share Option Scheme. The options had an exercise price of 1 pence per share and the notice of exercise was received on 9 February 2018.

 

Application has been made for the 800,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"), and dealings are expected to commence on 15 February 2018. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

 

Following Admission, the total number of Ordinary Shares in issue with voting rights will be  490,663,367 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Confirmation of Director's shareholding

 

Following the above purchase, Ewan Phillips owns 4,682,111 ordinary shares representing 0.95% per cent. of the Company's issued share capital.

 

 

For further information, please contact:-

 

Deltex Medical Group plc                               

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman                


Ewan Phillips, Chief Executive   


Jonathan Shaw, Group Finance Director




Nominated Adviser & Broker


Arden Partners plc

020 7614 5900

 

Chris Hardie

Ciaran Walsh




Joint Broker


Turner Pope Investments (TPI) Ltd

0203 621 4120

info@turnerpope.com

Andy Thacker


 

Financial Public Relations


IFC Advisory Ltd

0203 053 8671

 

Tim Metcalfe

Graham Herring

Heather Armstrong


 

PDMR Notification Forms:

 

The notifications below are made in accordance with the requirements of MAR.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ewan Phillips

2.

Reason for the Notification

a)

Position/status

Chief Executive

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Deltex Medical Group plc

b)

LEI

N/A

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence each

Identification code

GB00B95L0551

b)

Nature of the Transaction

Exercise of share options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1p

800,000

d)

Aggregated information

Aggregated volume Price

N/A (Single transaction)

e)

Date of the transaction

15 February 2018

f)

Place of the transaction

London Stock Exchange, AIM

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLIFFAFSIFLIT
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.